ArticleFrontiers in oncology2025

Sintilimab plus a bevacizumab biosimilar (IBI305) in advanced HCC with Child-Pugh A/B liver function: a real-world multicenter retrospective study.

Yuanxu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.